Amprologix files the first of a new series of patents protecting novel molecular structures for the treatment of bacterial infections.
July 2024
Amprologix has filed its first patent in a series aimed at developing novel molecular structures for the treatment of bacterial infections. This significant milestone stems from discoveries made by Amprologix's proprietary AI “discovery engine,” which has been pivotal in identifying new therapeutic candidates.
